newsbiomarker testingmetastatic NSCLC
Rates of Systemic Treatment for Metastatic Non-Small Cell Lung Cancer Among Older Adults
By MedXY|May 12, 2026
A population-based study of older adults with metastatic NSCLC found that fewer than half received systemic treatment, with only slight improvement over time. Oncology referral and biomarker testing were strongly linked to treatment, while
